NYSE - Delayed Quote USD

DaVita Inc. (DVA)

133.51

+0.74

(+0.56%)

At close: April 26 at 4:00 PM EDT

134.18

+0.67

(+0.50%)

Pre-Market: 8:05 AM EDT

DaVita's Global Operations Powered by 100% Renewable Energy

By 2025, DaVita (NYSE: DVA), a leading provider of kidney care services, expects to match 100% of its electricity use across its global operations with renewable energy purchases. DaVita has contracted with ACCIONA Energía on a virtual power purchase agreement (PPA) facilitating the development of clean energy projects in Spain. This announcement follows DaVita reaching 100% renewable in its North American operations in December 2021.

PR Newswire 6 days ago
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

PR Newswire 11 days ago
DaVita Announces Dennis Pullin to its Board of Directors

DaVita Inc. today announced that its Board of Directors has appointed a new independent director, Dennis Pullin, to join the Board, effective April 10, 2024.

PR Newswire 18 days ago
The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On

Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on advancing chronic disease prevention, specifically addressing two of the most prevalent chronic conditions in the U.S. — diabetes and chronic kidney disease (CKD). The kick-off for this expanded effort coincides with National Kidney Month, a time when both organizations bolster efforts to increase kidney health awar

PR Newswire last month
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at Barclays Global Healthcare Conference 2024 on Wednesday, March 13, 2024, at 8:00 a.m. EDT.

PR Newswire last month
DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador

DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia, and its entry into Chile and Ecuador. The deal, which is consistent with DaVita's disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD. The transaction in Chile closed effective today. The transactions in Ecuador, Colombia and Braz

PR Newswire last month
DaVita Inc. to Participate in the TD Cowen's Health Care Conference 2024

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at TD Cowen's Health Care Conference 2024 on Monday, March 4, 2024, at 11:10 a.m. EST.

PR Newswire last month
DaVita Inc. 4th Quarter 2023 Results

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2023.

PR Newswire 2 months ago
DaVita Inc. Schedules 4th Quarter 2023 Investor Conference Call

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 13, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

PR Newswire 3 months ago
DaVita Giving Foundation Invests $1 Million in Western Governors University to Support Nursing Students

The DaVita Giving Foundation has awarded Western Governors University's (WGU) Michael O. Leavitt School of Health (LSH) a $1 million grant over the next three years to support more than 1,500 nursing students in Start Early, a program co-created by DaVita Inc. and WGU to help increase nursing degree completion at the university nationwide.

PR Newswire 4 months ago
DaVita's 'Move It With Purpose' Event Achieves Record-Breaking Participation to Support Life-Saving Care

DaVita, a leading provider of kidney care services, today announced the success of its 2023 Move It With Purpose (MIWP) event. MIWP is an annual community-driven initiative that brings together DaVita teammates, friends, family members, and the kidney care community to support Bridge of Life, a nonprofit founded by DaVita to support the prevention and treatment of chronic disease.

PR Newswire 4 months ago
DaVita Inc. 3rd Quarter 2023 Results

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023.

PR Newswire 5 months ago
DaVita Unveils New Research to Drive Health Equity and Improve Care Quality during Annual American Society of Nephrology Meeting

DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc., is presenting the findings of five new research projects at the American Society of Nephrology (ASN)'s annual "Kidney Week," which is currently underway in Philadelphia. The studies are focused on driving health equity and reducing hospitalizations, among other outcomes.

PR Newswire 5 months ago
DaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care

DaVita Inc. (NYSE: DVA) and Google Cloud today announced that the organizations have collaborated to create a new clinical operating system that sets a foundation for streamlined kidney care for more than 200,000 DaVita patients.

PR Newswire 6 months ago
DaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

PR Newswire 6 months ago
DaVita Statement on GLP-1 and Potential Implications on Chronic Kidney Disease

DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes, related to its FLOW study that sought to demonstrate that Ozempic delays progression of chronic kidney disease (CKD) and lowers the risk of kidney and cardiovascular mortality. The following statement can be attributed to Dr. Jeff Giullian, chief medical officer for DaVita Inc.

PR Newswire 6 months ago
DaVita launches community health tour to provide free kidney screenings and education coast-to-coast

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services, today announced the launch of its 2023 Health Tour, a mobile health screening and kidney care education program supporting local communities across the country. The tour will help identify and raise awareness of risk factors that may lead to chronic kidney disease (CKD), including obesity, diabetes, high blood pressure and a family history of kidney failure.

PR Newswire 7 months ago
DaVita and Adtalem collaborate to address growing nephrology nursing shortage

DaVita Inc., a leading kidney care provider, has joined forces with Adtalem Global Education, to launch the "Introduction to Nephrology Nursing" curriculum as a part of the Practice Ready. Specialty Focused. ™ (PRSF) initiative at one of its institutions, Chamberlain University. Designed to prepare pre-licensure nursing students for careers within the industry's most in-demand fields, the PRSF program introduces students to health care specialty options available with one-on-one clinical experie

PR Newswire 7 months ago
DaVita Inc. to Participate in Fireside Chat with UBS

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat hosted by UBS on Thursday, September 14, 2023, at 11:30 am EDT. To view the live webcast, visit the UBS page here and create a free registration.

PR Newswire 7 months ago
DaVita Inc. 2nd Quarter 2023 Results

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2023.

PR Newswire 8 months ago

Performance Overview

Return	DVA	S&P 500
YTD	+27.44%	+6.92%
1-Year	+52.93%	+25.26%
3-Year	+17.53%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

DaVita Inc. (DVA)

DaVita's Global Operations Powered by 100% Renewable Energy

DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call

DaVita Announces Dennis Pullin to its Board of Directors

The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador

DaVita Inc. to Participate in the TD Cowen's Health Care Conference 2024

DaVita Inc. 4th Quarter 2023 Results

DaVita Inc. Schedules 4th Quarter 2023 Investor Conference Call

DaVita Giving Foundation Invests $1 Million in Western Governors University to Support Nursing Students

DaVita's 'Move It With Purpose' Event Achieves Record-Breaking Participation to Support Life-Saving Care

DaVita Inc. 3rd Quarter 2023 Results

DaVita Unveils New Research to Drive Health Equity and Improve Care Quality during Annual American Society of Nephrology Meeting

DaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care

DaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call

DaVita Statement on GLP-1 and Potential Implications on Chronic Kidney Disease

DaVita launches community health tour to provide free kidney screenings and education coast-to-coast

DaVita and Adtalem collaborate to address growing nephrology nursing shortage

DaVita Inc. to Participate in Fireside Chat with UBS

DaVita Inc. 2nd Quarter 2023 Results

Performance Overview